Crossref

1. LL37-rIb-AMP4 Hybrid Peptide as a Therapy for Systematic Infections of Acinetobacter baumannii, Pseudomonas aeruginosa, Vancomycin-resistant Enterococcus (VRE), and Methicillin-resistant Staphylococcus aureus (MRSA) cells in a mouse model.

- shabnam Sadoogh Abbasian

- Ali Sadoogh Abbasian

- Ehsanollah Ghaznavi-Rad

- Ehsan Zarei-Mehrvarz

- Samira Sadelaji

- Hamid Abtahi

2. The LL-37 Antimicrobial Peptide as a Treatment for Systematic Infection of Acinetobacter baumannii in a Mouse Model

- Ehsan Zarei-Mehrvarz

- Shohreh Fahimirad

- Ehsanollah Ghaznavi-rad

- Shabnam Sadoogh Abbasian

- Hamid Abtahi